Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial

被引：0
|
作者：
Eichhorst, Barbara [1 ,2 ]
Hacken, Elisa ten [3 ]
机构：
[1] Univ Cologne, Dept Internal Med, Cologne, Germany
[2] Univ Cologne, Ctr Integrated Oncol Aachen, Cologne, Germany
[3] Weill Cornell Med, Dept Med, Div Hematol Oncol, New York, NY 10065 USA
来源：
SEMINARS IN HEMATOLOGY | 2024年 / 61卷 / 02期
关键词：
CD38; EXPRESSION; CLL; MUTATIONS; EVOLUTION; SURVIVAL; FEATURES; IMPACT;
D O I：
10.1053/j.seminhematol.2024.03.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：69 / 72
页数：4
相关论文
共 50 条
  • [31] A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia
    Friedman, Daphne R.
    Weinberg, J. Brice
    Barry, William T.
    Goodman, Barbara K.
    Volkheimer, Alicia D.
    Bond, Karen M.
    Chen, Youwei
    Jiang, Ning
    Moore, Joseph O.
    Gockerman, Jon P.
    Diehl, Louis F.
    Decastro, Carlos M.
    Potti, Anil
    Nevins, Joseph R.
    CLINICAL CANCER RESEARCH, 2009, 15 (22) : 6947 - 6955
  • [32] Diagnosis and Treatment Options in Low-Risk Chronic Lymphocytic Leukemia
    Musteata, Larisa
    Musteata, Vasile
    Urescu, Dumitrita
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S314 - S315
  • [33] Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease"
    Noels, Heidi
    Jankowski, Joachim
    TOXINS, 2020, 12 (06)
  • [34] Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review
    Islam, Prioty
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (09) : 1259 - 1273
  • [35] Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia
    Khurana, Sharad
    Ahmed, Salman
    Alegria, Victoria R.
    Aulakh, Sonikpreet
    Ailawadhi, Meghna
    Singh, Anshika
    Chanan-Khan, Asher
    Ailawadhi, Sikander
    SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
  • [36] Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia
    Janovska, Pavlina
    Verner, Jan
    Kohoutek, Jiri
    Bryjova, Lenka
    Gregorova, Michaela
    Dzimkova, Marta
    Skabrahova, Hana
    Radaszkiewicz, Tomasz
    Ovesna, Petra
    Blanarova, Olga Vondalova
    Nemcova, Tereza
    Hoferova, Zuzana
    Vasickova, Katerina
    Smyckova, Lucie
    Egle, Alexander
    Pavlova, Sarka
    Poppova, Lucie
    Plevova, Karla
    Pospisilova, Sarka
    Bryja, Vitezslav
    BLOOD, 2018, 131 (11) : 1206 - 1218
  • [37] Evaluation of Interleukin-9 Expression as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia in a Cohort of Egyptian Patients
    Abbassy, Hadeer A.
    Aboelwafa, Reham A.
    Ghallab, Omar M.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (04) : 477 - 482
  • [38] Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients
    Navrkalova, Veronika
    Kafkova, Leona Raskova
    Divoky, Vladimir
    Pospisilova, Sarka
    HAEMATOLOGICA, 2015, 100 (08) : 994 - 996
  • [39] Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
    Buchner, Maike
    Fuchs, Simon
    Prinz, Gabriele
    Pfeifer, Dietmar
    Bartholome, Kilian
    Burger, Meike
    Chevalier, Nina
    Vallat, Laurent
    Timmer, Jens
    Gribben, John G.
    Jumaa, Hassan
    Veelken, Hendrik
    Dierks, Christine
    Zirlik, Katja
    CANCER RESEARCH, 2009, 69 (13) : 5424 - 5432
  • [40] Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia
    Jitschin, Regina
    Hofmann, Andreas D.
    Bruns, Heiko
    Giessl, Andreas
    Bricks, Juliane
    Berger, Jana
    Saul, Domenica
    Eckart, Michael J.
    Mackensen, Andreas
    Mougiakakos, Dimitrios
    BLOOD, 2014, 123 (17) : 2663 - 2672
12345